Clinical trials
Phase 2 Herpes Zoster trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 8 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
| Terminated | 4 |
| Not yet recruiting | 4 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 8 |
| NeurogesX | 5 |
| Merck Sharp & Dohme LLC | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Pfizer | 2 |
| Aestus Therapeutics | 1 |
| Aribio Lab Co., Ltd. | 1 |
| Astellas Pharma Inc | 1 |
| Bausch Health Americas, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Herpes Zoster | 50 |
| Neuralgia, Postherpetic | 16 |
| Chickenpox | 14 |
| Neuralgia | 13 |
| Pain | 9 |
| HIV Infections | 5 |
| Peripheral Nervous System Diseases | 5 |
| Diabetes Mellitus | 3 |
| Diabetic Neuropathies | 3 |
| Agnosia | 2 |
Trials
Showing 76 to 50 of 50. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.